bf/NASDAQ:RIGL_icon.jpeg

NASDAQ:RIGL

Rigel Pharmaceuticals, Inc.

  • Stock

USD

Last Close

10.90

26/07 20:00

Market Cap

150.83M

Beta: 0.73

Volume Today

58.14K

Avg: 2.73M

PE Ratio

−8.04

PFCF: −5.71

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
7.15M
-
8.25M
15.38%
28.89M
250.24%
20.38M
29.46%
4.48M
78.00%
44.51M
892.62%
59.29M
33.20%
108.62M
83.21%
149.24M
37.39%
120.24M
19.43%
116.88M
2.79%
cost of revenue
287K
-
906K
215.68%
895K
1.21%
1.08M
21.01%
1.75M
61.50%
7.11M
306.52%
gross profit
7.15M
-
8.25M
15.38%
28.89M
250.24%
20.38M
29.46%
4.48M
78.00%
44.22M
886.22%
58.38M
32.02%
107.73M
84.52%
148.15M
37.53%
118.49M
20.02%
109.77M
7.36%
selling and marketing expenses
general and administrative expenses
19.61M
-
31.80M
62.16%
17.81M
43.99%
20.91M
17.37%
37.83M
80.94%
70.00M
85.04%
selling general and administrative expenses
19.61M
-
31.80M
62.16%
17.81M
43.99%
20.91M
17.37%
37.83M
80.94%
70.00M
85.04%
74.59M
6.55%
76.60M
2.69%
91.89M
19.97%
112.45M
22.37%
105.74M
5.97%
research and development expenses
75.33M
-
67.70M
10.13%
62.83M
7.20%
63.45M
0.99%
46.27M
27.07%
46.90M
1.37%
52.88M
12.75%
60.10M
13.64%
65.24M
8.55%
60.27M
7.61%
24.52M
59.31%
other expenses
3.52M
-
1.32M
62.51%
cost and expenses
94.94M
-
99.50M
4.80%
80.64M
18.96%
84.35M
4.61%
84.10M
0.30%
117.19M
39.35%
128.38M
9.55%
137.59M
7.18%
158.21M
14.98%
174.47M
10.28%
137.37M
21.26%
operating expenses
94.94M
-
99.50M
4.80%
80.64M
18.96%
84.35M
4.61%
84.10M
0.30%
116.91M
39.01%
127.47M
9.04%
136.70M
7.24%
157.13M
14.94%
172.72M
9.93%
130.26M
24.58%
interest expense
335K
-
1.35M
303.88%
4.86M
259.20%
3.71M
23.72%
6.87M
85.38%
ebitda
-84.76M
-
-91.35M
7.78%
-51.80M
43.29%
-58.29M
12.53%
-80.35M
37.84%
-72.68M
9.54%
-66.56M
8.43%
-28.39M
57.34%
-8.93M
68.55%
-53.55M
499.75%
-16.98M
68.29%
operating income
-89.47M
-
-91.25M
1.99%
-51.74M
43.29%
-69.74M
34.78%
-79.62M
14.16%
-72.68M
8.71%
-69.09M
4.94%
-28.97M
58.07%
-8.97M
69.02%
-54.23M
504.23%
-20.49M
62.21%
depreciation and amortization
2.59M
-
2.36M
8.99%
1.44M
39.00%
941K
34.61%
465K
50.58%
594K
27.74%
2.53M
326.26%
582K
77.01%
47K
91.92%
684K
1,355.32%
1.24M
80.99%
total other income expenses net
-1.68M
-
98K
105.84%
57K
41.84%
-5.68M
10,068.42%
732K
112.88%
2.20M
200.96%
2.20M
0.27%
-771K
135.09%
-8.33M
980.93%
-4.34M
47.89%
-4.60M
5.92%
income before tax
-89.03M
-
-90.91M
2.11%
-51.46M
43.39%
-69.22M
34.49%
-77.99M
12.68%
-70.48M
9.63%
-66.89M
5.09%
-29.74M
55.54%
-17.31M
41.81%
-58.57M
238.40%
-25.09M
57.16%
income tax expense
-2.70M
-
-1.72M
36.37%
4.30M
350.52%
-2.09M
148.54%
2.20M
205.46%
-348K
115.80%
647K
285.92%
605K
6.49%
3.02M
399.67%
2.27M
24.84%
net income
-89.03M
-
-90.91M
2.11%
-51.46M
43.39%
-69.22M
34.49%
-77.99M
12.68%
-70.48M
9.63%
-66.55M
5.58%
-30.39M
54.33%
-17.91M
41.05%
-61.60M
243.84%
-25.09M
59.27%
weighted average shs out
87.29M
-
87.66M
0.43%
88.43M
0.88%
94.39M
6.73%
126.32M
33.84%
160.53M
27.08%
167.40M
4.28%
168.75M
0.81%
170.49M
1.03%
172.41M
1.12%
174.02M
0.93%
weighted average shs out dil
87.29M
-
87.66M
0.43%
88.43M
0.88%
94.39M
6.73%
126.32M
33.84%
160.53M
27.08%
167.40M
4.28%
168.75M
0.81%
170.49M
1.03%
172.41M
1.12%
174.02M
0.93%
eps
-1.02
-
-1.04
1.96%
-0.58
44.23%
-0.73
25.86%
-0.62
15.07%
-0.44
29.03%
-0.40
9.09%
-0.18
55.00%
-0.11
38.89%
-0.36
227.27%
-0.14
61.11%
epsdiluted
-1.02
-
-1.04
1.96%
-0.58
44.23%
-0.73
25.86%
-0.62
15.07%
-0.44
29.03%
-0.40
9.09%
-0.18
55.00%
-0.11
38.89%
-0.36
227.27%
-0.14
61.11%

All numbers in USD (except ratios and percentages)